Justin Smith

Stock Analyst at Societe Generale

(1.39)

# 2,619

Out of 4,479 analysts

6

Total ratings

50%

Success rate

9.4%

Average return

Main Sectors:

Top Industries:

Drug Manufacturers - General

3 Stocks

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	MRK Merck & Co.	Downgrades: Sell	$104	$127.90	-18.69%	1	Mar 11, 2024
	ABBV AbbVie	Downgrades: Hold	n/a	$170.37	-	3	Nov 8, 2022
	BMY Bristol-Myers Squibb Company	Upgrades: Buy	n/a	$41.30	-	2	Nov 16, 2020

Merck & Co.

Mar 11, 2024

Downgrades: Sell

Price Target: $104

Current: $127.90

Upside: -18.69%

AbbVie

Nov 8, 2022

Downgrades: Hold

Price Target: n/a

Current: $170.37

Upside: -

Bristol-Myers Squibb Company

Nov 16, 2020

Upgrades: Buy

Price Target: n/a

Current: $41.30

Upside: -